Request Demo
Last update 08 May 2025
Cenicriviroc mesylate/Tropifexor
Last update 08 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Cenicriviroc/tropifexor, Tropifexor/Cenicriviroc, CVC/LJN452 + [1] |
Target |
Action antagonists, agonists |
Mechanism CCR2 antagonists(C-C chemokine receptor type 2 antagonists), CCR5 antagonists(C-C chemokine receptor type 5 antagonists), FXR agonists(Bile acid receptor FXR agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC42H56N4O7S2 |
InChIKeyIXPBPUPDRDCRSY-YLZLUMLXSA-N |
CAS Registry497223-28-6 |
View All Structures (2)
Related
2
Clinical Trials associated with Cenicriviroc mesylate/TropifexorCTRI/2018/06/014509
A randomized, double-blind, placebo controlled, 3- part,adaptive design, multicenter study to assesssafety, tolerability and efficacy of tropifexor (LJN452) in patients withnon-alcoholic steatohepatitis (NASH) - NASH
NCT02855164
A Randomized, Double-blind, Placebo Controlled, 3- Part, Adaptive Design, Multicenter Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH): FLIGHT-FXR
100 Clinical Results associated with Cenicriviroc mesylate/Tropifexor
Login to view more data
100 Translational Medicine associated with Cenicriviroc mesylate/Tropifexor
Login to view more data
100 Patents (Medical) associated with Cenicriviroc mesylate/Tropifexor
Login to view more data
100 Deals associated with Cenicriviroc mesylate/Tropifexor
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Fibrosis, Liver | Phase 2 | United States | 11 Sep 2018 | |
| Fibrosis, Liver | Phase 2 | Argentina | 11 Sep 2018 | |
| Fibrosis, Liver | Phase 2 | Belgium | 11 Sep 2018 | |
| Fibrosis, Liver | Phase 2 | Canada | 11 Sep 2018 | |
| Fibrosis, Liver | Phase 2 | Czechia | 11 Sep 2018 | |
| Fibrosis, Liver | Phase 2 | Egypt | 11 Sep 2018 | |
| Fibrosis, Liver | Phase 2 | France | 11 Sep 2018 | |
| Fibrosis, Liver | Phase 2 | Germany | 11 Sep 2018 | |
| Fibrosis, Liver | Phase 2 | India | 11 Sep 2018 | |
| Fibrosis, Liver | Phase 2 | Israel | 11 Sep 2018 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free